GPX1-driven selenium nanoplatform reprograms MAMs-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease
Theranostics · 30.08.2025 · 15 (18) · 9601-9622
DOI: 10.7150/thno.117582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 30.08.2025. Verfasst von Yao Tan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, Yuelu District, Changsha City 410013, Hunan…. Hauptthemen laut MEDLINE: Selenium, Graves Ophthalmopathy, Nanoparticles, Adipose Tissue. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, Yuelu District, Changsha City 410013, Hunan Province, China.
- Postdoctoral Station of Clinical Medicine, The Third Xiangya Hospital, Central South University, Changsha City 410013, Hunan Province, China.
- The First Affiliated Hospital of Hunan University of Chinese Medicine, Hunan Ophthalmic Disease (Traditional Chinese Medicine) Clinical Research Center, Changsha City 410000, Hunan Province, China.
- Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
- Postdoctoral Station of Medical Aspects of Specific Environments, the Third Xiangya Hospital, Central South University, Changsha City 410013, China.
Zitieren
APA
Tan, Y., Zhang, F., Cao, J., Feng, L., Xie, B., Gao, L., Chen, X., Yan, Z., & Xiong, W. (2025). GPX1-driven selenium nanoplatform reprograms MAMs-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease. Theranostics, 15(18), 9601-9622. https://doi.org/10.7150/thno.117582
Vancouver
Tan Y, Zhang F, Cao J, Feng L, Xie B, Gao L, et al. GPX1-driven selenium nanoplatform reprograms MAMs-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease. Theranostics. 2025;15(18):9601-9622. doi:10.7150/thno.117582
BibTeX
@article{Tan2025,
author = {Tan, Yao and Zhang, Feng and Cao, Jiamin and Feng, Lemeng and Xie, Bingyu and Gao, Limo and Chen, Xiangdong and Yan, Zuyun and Xiong, Wei},
title = {GPX1-driven selenium nanoplatform reprograms MAMs-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {18},
pages = {9601--9622},
doi = {10.7150/thno.117582}
}
EUVIMED